REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2025 >

Decisions 1st July 2025

The following decisions were made at the Joint Formulary Group meeting held on Tuesday 1st July:

New Drug Requests

Betamethasone (as valerate) 0.1% w/w scalp application (Betacap) (TLS Green)

Capasal Therapeutic Shampoo (TLS Green)

Shared Care Protocols

The following shared care protocols have been updated: 

  • Sodium valproate

Traffic Light Status Changes

Pimecrolimus 1% cream (Elidel®) TLS changed from amber to green

NICE Technology Appraisals traffic light status discussions:

  • Somapacitan for treating growth hormone deficiency in people 3 to 17 years will be added to the Formulary as TLS Red within the NICE implementation period. 

 

Other discussions/decisions

- Melatonin Shared Care Protocol needs to be reviewed to reflect updated product costs

- The new drug request application template form has been updated - see paperwork